ASTL and pancreatic neoplasm: The PDAC PDX mouse models examined in this study, where patient tumors are affixed directly into the mouse pancreas [22], may represent a suitable system for studying effects of anti-SAS1B therapies in vivo, along with assessment of SAS1B expression in the current murine genetic models of pancreatic cancers.